{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:05:33Z","timestamp":1788930333048,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21822-9","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:23:13Z","timestamp":1761830593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Synergistic effects of colistin-based combinations against colistin and carbapenem-resistant Klebsiella pneumoniae isolated from nosocomial bloodstream infections"],"prefix":"10.1038","volume":"15","author":[{"given":"Bahman","family":"Pourabbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima","family":"Sepehrpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Asaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Abbasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Pourabbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"issue":"6","key":"21822_CR1","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/cid\/ciw805","volume":"64","author":"LJ Rojas","year":"2017","unstructured":"Rojas, L. J. et al. Colistin resistance in carbapenem-resistant Klebsiella pneumoniae: Laboratory detection and impact on mortality. Clin. Infect. Dis. 64 (6), 711\u2013718 (2017).","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"21822_CR2","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3390\/pathogens11101092","volume":"11","author":"LI Uzairue","year":"2022","unstructured":"Uzairue, L. I. et al. Global prevalence of colistin resistance in Klebsiella pneumoniae from bloodstream infection: A systematic review and meta-analysis. Pathogens 11 (10), 1092 (2022).","journal-title":"Pathogens"},{"issue":"12","key":"21822_CR3","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.cmi.2015.08.001","volume":"21","author":"D Giacobbe","year":"2015","unstructured":"Giacobbe, D. et al. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case\u2013control\u2013control study. Clin. Microbiol. Infect. 21 (12), 1106 (2015). e1-1106. e8.","journal-title":"Clin. Microbiol. Infect."},{"issue":"6","key":"21822_CR4","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1128\/JCM.02301-09","volume":"48","author":"O Zarkotou","year":"2010","unstructured":"Zarkotou, O. et al. Risk factors and outcomes associated with acquisition of colistin-resistant KPC-producing Klebsiella pneumoniae: A matched case-control study. J. Clin. Microbiol. 48 (6), 2271\u20132274 (2010).","journal-title":"J. Clin. Microbiol."},{"issue":"17","key":"21822_CR5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/MD.0000000000000111","volume":"93","author":"N Girometti","year":"2014","unstructured":"Girometti, N. et al. Klebsiella pneumoniae bloodstream infection: Epidemiology and impact of inappropriate empirical therapy. Med. (Baltim). 93 (17), 298\u2013309 (2014).","journal-title":"Med. (Baltim)."},{"issue":"4","key":"21822_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/21505594.2017.1292196","volume":"8","author":"EM Trecarichi","year":"2017","unstructured":"Trecarichi, E. M. & Tumbarello, M. Therapeutic options for carbapenem-resistant Enterobacteriaceae infections. Virulence 8 (4), 470\u2013484 (2017).","journal-title":"Virulence"},{"issue":"6","key":"21822_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/QCO.0b013e328332e672","volume":"22","author":"RL Nation","year":"2009","unstructured":"Nation, R. L. & Li, J. Colistin in the 21st century. Curr. Opin. Infect. Dis. 22 (6), 535\u2013543 (2009).","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"3","key":"21822_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/cid\/cit253","volume":"57","author":"E Durante-Mangoni","year":"2013","unstructured":"Durante-Mangoni, E. et al. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant acinetobacter baumannii: A multicenter, randomized clinical trial. Clin. Infect. Dis. 57 (3), 349\u2013358 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"21822_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jgar.2020.08.024","volume":"23","author":"SY Hou","year":"2020","unstructured":"Hou, S. Y., Wu, D. & Feng, X. H. Polymyxin monotherapy versus polymyxin-based combination therapy against carbapenem-resistant Klebsiella pneumoniae: A systematic review and meta-analysis. J. Global Antimicrob. Resist. 23, 197\u2013202 (2020).","journal-title":"J. Global Antimicrob. Resist."},{"key":"21822_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0031-6997(25)06847-4","volume":"47","author":"WR Greco","year":"1995","unstructured":"Greco, W. R. The search for synergy: A critical review from a response surface perspective. Pharmacol. Rev. 47, 331\u2013385 (1995).","journal-title":"Pharmacol. Rev."},{"issue":"1695","key":"21822_CR11","doi-asserted-by":"publisher","first-page":"20150294","DOI":"10.1098\/rstb.2015.0294","volume":"371","author":"DY Baeder","year":"2016","unstructured":"Baeder, D. Y. et al. Antimicrobial combinations: Bliss independence and Loewe additivity derived from mechanistic multi-hit models. Philosophical Trans. Royal Soc. B: Biol. Sci. 371 (1695), 20150294 (2016).","journal-title":"Philosophical Trans. Royal Soc. B: Biol. Sci."},{"issue":"5","key":"21822_CR12","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1128\/AAC.01758-13","volume":"58","author":"Voor In 't Holt AF","year":"2014","unstructured":"Voor In Holt, AF. et al . A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 58 (5), 2626\u20132637 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"21822_CR13","doi-asserted-by":"publisher","first-page":"101543","DOI":"10.1016\/j.mex.2021.101543","volume":"8","author":"P Bellio","year":"2021","unstructured":"Bellio, P. et al. New and simplified method for drug combination studies by checkerboard assay. MethodsX 8, 101543 (2021).","journal-title":"MethodsX"},{"issue":"18","key":"21822_CR14","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","volume":"32","author":"GY Di Veroli","year":"2016","unstructured":"Di Veroli, G. Y. et al. Combenefit: an interactive platform for the analysis and visualization of drug combinations. Bioinformatics 32 (18), 2866\u20132868 (2016).","journal-title":"Bioinformatics"},{"issue":"3","key":"21822_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"TC Chou","year":"2006","unstructured":"Chou, T. C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 58 (3), 621\u2013681 (2006).","journal-title":"Pharmacol. Rev."},{"issue":"10","key":"21822_CR16","doi-asserted-by":"publisher","first-page":"e00873","DOI":"10.1128\/AAC.00873-18","volume":"62","author":"T Brennan-Krohn","year":"2018","unstructured":"Brennan-Krohn, T., Pironti, A. & Kirby, J. E. Synergistic activity of colistin-containing combinations against colistin-resistant Enterobacteriaceae. Antimicrob. Agents Chemother. 62 (10), e00873\u2009\u2013\u200918 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"21822_CR17","doi-asserted-by":"publisher","first-page":"e0244673","DOI":"10.1371\/journal.pone.0244673","volume":"16","author":"JC Ontong","year":"2021","unstructured":"Ontong, J. C. et al. Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and Piperacillin on multidrug resistant Klebsiella pneumoniae isolates. Plos One. 16 (1), e0244673 (2021).","journal-title":"Plos One"},{"issue":"6","key":"21822_CR18","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1021\/acsinfecdis.0c00661","volume":"7","author":"N Abdul Rahim","year":"2021","unstructured":"Abdul Rahim, N. et al. Synergy of the polymyxin-chloramphenicol combination against new Delhi metallo-\u03b2-lactamase-producing Klebsiella pneumoniae is predominately driven by Chloramphenicol. ACS Infect. Dis. 7 (6), 1584\u20131595 (2021).","journal-title":"ACS Infect. Dis."},{"issue":"1","key":"21822_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrmicro3155","volume":"12","author":"DN Wilson","year":"2014","unstructured":"Wilson, D. N. Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat. Rev. Microbiol. 12 (1), 35\u201348 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"21822_CR20","unstructured":"Bennett, J. E., Dolin, R. & Blaser, M. J. Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases E-Book: 2-volume set (Elsevier health sciences, 2019)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21822-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21822-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21822-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:23:14Z","timestamp":1761830594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21822-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21822"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21822-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study received ethical approval from the Ethics Committee of Professor Alborzi Clinical Microbiology Research Center and from the Ethics Committee of Shiraz University of Medical Sciences (SUMS), Shiraz, Iran (Approval Code: IR.SUMS.REC.1401.618). As this was a retrospective study using anonymized clinical data, the requirement for informed consent was waived by the same Ethics Committees in accordance with national guidelines and institutional policies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"All experiments were carried out in accordance with the relevant guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Accordance statement"}}],"article-number":"38022"}}